 |
|
|
| |
Real-world use of elbasvir/grazoprevir and outcomes in patients with
Chronic Hepatitis C: Retrospective data analyses from the TRIO Network.
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
B. Bacon1, M. Curry2, D. Dieterich3, S.L. Flamm4, K.Kowdley5, S.Milligan6, C. Nwankwo7, N. Tsai8, Z. Younossi9 and N. Afdhal2
1Saint Louis University School of Medicine, St. Louis, MO USA, 2Beth Israel Deaconess Medical Center, Boston, MA USA, 3Icahn School of Medicine at Mount Sinai, New York, NY USA, 4Northwestern University Feinberg School of Medicine, Chicago IL USA, 5Liver Care Network, Swedish Medical Center, Seattle, WA USA, 6Trio Health Analytics, La Jolla, CA USA, 7Merck & Co., Inc., Kenilworth, NJ USA, 8Queens Medical Center, University of Hawaii, Honolulu, HI USA and 9Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA USA
|
| |
|
|
|
|
|
